Douglas is a Ph.D. candidate in Bioengineering at Stanford studying therapeutic protein engineering. He earned a B.S. in chemical engineering at the University of California, Santa Barbara, and a M.S. in bioengineering at Stanford University with an emphasis on cellular and molecular engineering. During his undergraduate years he completed two summer internships at Lawrence Livermore National Laboratory, and conducted research in chemical process design at UC Santa Barbara. Through his thesis research at Stanford he has engineered mutant proteins that specifically target a critical mediator of cancer metastasis. His ongoing studies comprise further characterization of these engineered mutants, in particular, focusing on their potential to inhibit cancer metastasis. I have also been helping to start a biomedical engineering student newsletter at Stanford. A couple articles and a link to the newsletter are provided below. Insights from Willem 'Pim' Stemmer: a pioneering biotech entrepreneur http://bmes.stanford.edu/Winter_2010/Entries/2010/2/14_Insights_from_Willem_Pim_Stemmer.html Genentech: Past, Present, and Future http://bmes.stanford.edu/Winter_2010/Entries/2010/1/22_Genentech%3A_Past,_Present,_and_Future.html Newsletter homepage: http://bmes.stanford.edu/Home.html
Ph.D. , Bioengineering
Class of 2010